Are you Dr. Ojalvo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
622 W 168th St
PH 16
New York, NY 10032Phone+1 212-305-2376
Summary
- Dr. Laureen Ojalvo, MD is an obstetrician/gynecologist in New York, New York. She is currently licensed to practice medicine in New York and Maryland.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Obstetrics and Gynecology, 2010 - 2014
Albert Einstein College of MedicineClass of 2010
Certifications & Licensure
MD State Medical License 2014 - 2017
NY State Medical License 2013 - 2015
Publications & Presentations
PubMed
- 104 citationsA STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice.Jeremy B. Foote, Marleen Kok, James M. Leatherman, Todd D. Armstrong, Bridget C. Marcinkowski
Cancer Immunology Research. 2017-06-01 - 113 citationsBintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase ...Luis Paz-Ares, Tae Min Kim, David Vicente, Enriqueta Felip, Dae Ho Lee
Journal of Thoracic Oncology. 2020-07-01 - 28 citationsBintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 CohortBenjamin Tan, Adnan Khattak, Enriqueta Felip, Karen Kelly, Patricia Rich
Targeted Oncology. 2021-05-19
